• Other Uses
  • U.S. Full Prescribing Information
  • Medication Guide
  • Indications
    Indications
  • En Español
  • Healthcare Professionals

1-833-ZEPOSIA

ZEPOSIA is a once-daily pill for adults with moderate to severe ulcerative colitis (UC).

Take as directed by your doctor if certain liver problems exist.

Phone icon

Call

MenuClose

ZEPOSIA is a once-daily pill for adults with moderate to severe ulcerative colitis (UC).

Take as directed by your doctor if certain liver problems exist.

What does it cost to take ZEPOSIA?

Generally, your out-of-pocket costs related to taking ZEPOSIA are determined by your insurance coverage and benefits, such as deductibles and co-insurance. This information is intended to help you understand the costs of ZEPOSIA.

ZEPOSIA® pill icon

Medication costs

  • The list price for the ZEPOSIA Starter Kit (the initial 28-dose supply) is $7,636.64
  • For a 30-dose supply of ZEPOSIA (regular daily dosage), the list price is $8,182.00
  • A co-pay savings offer is available to eligible, commercially insured patients
Financial support assistance icon

Medical costs

  • If you have commercial insurance, you may be eligible for reimbursement of out-of-pocket medical costs associated with getting started with ZEPOSIA

A Support Coordinator can help you better understand your costs and what financial support options are available to you.

Additional eligibility requirements and terms & conditions apply. Please click here for more information.

Which type of insurance coverage do you have?

ZEPOSIA prescription costs:

Your out-of-pocket costs for ZEPOSIA will be determined by your insurance coverage. But depending on your coverage and financial need, there may be ways to save on the cost of ZEPOSIA and the tests needed before treatment.

Additional eligibility requirements and terms & conditions apply. Please click here for more information.

ZEPOSIA® Co-pay Program icon

The co-pay savings offer

Eligible, commercially insured patients may pay as little as $0 a month for ZEPOSIA. Additional eligibility requirements and terms & conditions apply. Please click here for more information.

Enroll now

Costs for tests before treatment

Before you can begin taking ZEPOSIA, some routine testing is required. The tests can be done at a healthcare professional's office or at your home if you're eligible*:

Blood work—including complete blood count and liver function tests.

An electrocardiogram (ECG)—a common test that uses small sensors to monitor your heart and makes sure it’s working normally before you start treatment.

An eye exam—this may only be required for people with a history of macular edema, uveitis, or diabetes.

There may be costs associated with some of the routine medical tests, but depending on where these tests take place, eligible patients may qualify for reimbursement or incur no costs at all. Additional eligibility requirements and terms & conditions apply. Please click here for more information.

If you’re eligible, how will you be reimbursed?

If you accrue any costs associated with office visits (co-pay) or routine medical tests when starting ZEPOSIA, here’s what to do:

1 Save all the receipts related to the costs of your office visits and routine medical tests when starting treatment.
2 Save your Explanation of Benefits (EOB) form from your insurance carrier (it will be mailed or e-mailed to you).
3 Call 1-833-ZEPOSIA (833-937-6742) to initiate a medical rebate request. Once a benefits review is completed and your eligibility is confirmed, a representative will send you a personalized rebate form by mail.
4 Mail all receipts, EOB form, and the completed rebate form to the address specified on the form.
5 You’ll receive a check in the mail reimbursing you for what you paid (if eligible).
Insurance form icon

Get ZEPOSIA while you wait for insurance approval

The ZEPOSIA Bridge Program may provide help for eligible, commercially insured patients who are experiencing a delay in obtaining coverage or have been denied coverage.†

ZEPOSIA® 360 Support - support coordinator icon

Our Support Coordinators are available to help‡

1-833-ZEPOSIA (1-833-937-6742), Monday to Friday, 8 AM - 8 PM ET.

  • Patient must have a valid prescription for ZEPOSIA for an FDA-approved indication. Patients are not eligible if they have prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare, Medicaid, Medigap, CHAMPUS, TRICARE, Veterans Affairs (VA), or Department of Defense (DoD) programs, or reside in Rhode Island. To receive the In-Home Medical Services Program, the prescriber must request in-home assessment assistance through the ZEPOSIA 360 Support program. The patient’s insurance will not be billed, and the patient will not be responsible for any out-of-pocket costs. Patients who move from commercial plans to state or federal healthcare programs will no longer be eligible. The program cannot be combined with any other offer, rebate, coupon, or free trial. The program is not conditioned on any past, present, or future purchase, including refills. Only valid in the United States and US Territories. Void where prohibited by law, taxed, or restricted. The program is not insurance. Bristol-Myers Squibb Company reserves the right to rescind, revoke, or amend this program at any time without notice. Other limitations may apply.
  • The Bridge Program is available at no cost for eligible, commercially insured, on-label diagnosed patients if there is a delay in determining whether commercial prescription coverage is available, and is not contingent on any purchase requirement, for up to 24 months (dispensed in 30-day increments). The Bridge Program is not available to patients who have prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare, Medicaid, Medigap, CHAMPUS, TRICARE, Veterans Affairs (VA), or Department of Defense (DoD) programs and is available for no more than 12 months to patients in MA, MN, and RI. Appeal of any prior authorization denial must be made within 90 days or as per payer guidelines, to remain in the program. Eligibility will be re-verified in January for patients continuing into the following year, and may be at other times during program participation. Offer is not health insurance. Once coverage is approved by the patient’s commercial insurance plan, the patient will no longer be eligible. Void where prohibited by law, taxed, or restricted. Bristol-Myers Squibb Company reserves the right to rescind, revoke, or amend this program at any time without notice. Other limitations may apply.
  • While Support Coordinators can answer questions about ZEPOSIA 360 Support, they can not provide medical advice.

When covered, people who have prescription insurance through Medicare may pay $0.00 to $2,424.00 per month for ZEPOSIA.

Your costs are determined by your pharmacy coverage, such as Medicare Part D, Medicare Advantage (Part C), your coverage phase, and your income level. Use this link to learn about costs for Medicare drug coverage.

Certain patients may be eligible for the Low-Income Subsidy, also known as “Extra Help.” Use this link to learn more.

Your out-of-pocket costs for ZEPOSIA are determined by your insurance provider. To find out what your costs may be, please call a Support Coordinator (information below).*

If you have Medicaid

When covered, people with Medicaid may pay $0 to $20.00 per month for ZEPOSIA. To find out if you qualify for Medicaid, or to get more information about co-payments in your state, please visit the Medicaid website.

If you have difficulty affording medication, a Support Coordinator can help you understand your options.

ZEPOSIA® 360 Support - support coordinator icon

Our Support Coordinators are available to help‡

1-833-ZEPOSIA (833-937-6742), Monday to Friday, 8 AM - 8 PM ET.

  • While Support Coordinators can answer questions about ZEPOSIA 360 Support, they can not provide medical advice.

Costs for tests before treatment

Before you can begin taking ZEPOSIA, some routine testing is required:

Blood work—including complete blood count and liver function tests.

An electrocardiogram (ECG)—a common test that uses small sensors to monitor your heart and makes sure it’s working normally before you start treatment.

An eye exam—this may only be required for people with a history of macular edema, uveitis, or diabetes.

Regardless of where these appointments take place, you will pay what you normally would for an in-network office visit and/or tests.

If you do not have prescription drug coverage or your insurance does not cover ZEPOSIA, you can expect to pay the list price for ZEPOSIA of $7,636.64 for the ZEPOSIA Starter Kit (the initial 28-dose supply) or $8,182.00 for a 30-dose supply of the regular daily dosage of ZEPOSIA per month, with any additional pharmacy charges or discounts based on where you purchase your medicine.

If you’re uninsured or underinsured, and need assistance with co-pay or ZEPOSIA treatment costs, please reach out to a Support Coordinator to learn about the options available to you.

ZEPOSIA® 360 Support - support coordinator icon

Our Support Coordinators are available to help‡

1-833-ZEPOSIA (1-833-937-6742), Monday to Friday, 8 AM - 8 PM ET.

  • While Support Coordinators can answer questions about ZEPOSIA 360 Support, they can not provide medical advice.

See if you could save on treatment costs

Those who are eligible with commercial insurance may pay as little as $0 a month for ZEPOSIA with a co-pay savings offer Additional eligibility requirements and terms & conditions apply. Please click here for more information.

Enroll now

Are you starting or taking ZEPOSIA?

Sign up for ZEPOSIA 360 Support™ communications to receive resources, information, and support for starting and staying on treatment.

Sign up now

IMPORTANT SAFETY INFORMATION

Do not take ZEPOSIA if you:

  • have had a heart attack, chest pain (unstable angina), stroke or mini-stroke (transient ischemic attack or TIA), or certain types of heart failure in the last 6 months
  • have or have had a history of certain types of an irregular or abnormal heartbeat (arrhythmia) that is not corrected by a pacemaker
  • have untreated, severe breathing problems during your sleep (sleep apnea)
  • take certain medicines called monoamine oxidase (MAO) inhibitors (such as selegiline, phenelzine, linezolid)

Talk to your healthcare provider before taking ZEPOSIA if you have any of these conditions or do not know if you have any of these conditions.

ZEPOSIA may cause serious side effects, including:

  • Infections. ZEPOSIA can increase your risk of serious infections that can be life-threatening and cause death. ZEPOSIA lowers the number of white blood cells (lymphocytes) in your blood. This will usually go back to normal within 3 months of stopping treatment. Your healthcare provider may do a blood test of your white blood cells before you start taking ZEPOSIA.

    Call your healthcare provider right away if you have any of these symptoms of an infection during treatment with ZEPOSIA and for 3 months after your last dose of ZEPOSIA:

    • fever
    • feeling very tired
    • flu-like symptoms
    • cough
    • painful and frequent urination (signs of a urinary tract infection)
    • rash
    • headache with fever, neck stiffness, sensitivity to light, nausea, or confusion (these may be symptoms of meningitis, an infection of the lining around your brain and spine)

    Your healthcare provider may delay starting or may stop your ZEPOSIA treatment if you have an infection.

  • Progressive multifocal leukoencephalopathy (PML). ZEPOSIA can increase your risk for PML, which is a rare brain infection that usually leads to death or severe disability. If PML happens, it usually happens in people with weakened immune systems but has happened in people who do not have weakened immune systems. Symptoms of PML get worse over days to weeks. Call your doctor right away if you have any new or worsening symptoms of PML that have lasted several days, including: weakness on one (1) side of your body, changes in your vision, changes in your thinking or memory, confusion, changes in your personality, loss of coordination in your arms or legs, decreased strength, and/or problems with balance.
  • Slow heart rate (also known as bradyarrhythmia) when you start taking ZEPOSIA. ZEPOSIA may cause your heart rate to temporarily slow down, especially during the first 8 days. You will have a test to check the electrical activity of your heart called an electrocardiogram (ECG) before you take your first dose of ZEPOSIA.

    Call your healthcare provider if you experience the following symptoms of slow heart rate:

    • dizziness
    • lightheadedness
    • feeling like your heart is beating slowly or skipping beats
    • shortness of breath
    • confusion
    • chest pain
    • tiredness

Follow directions from your healthcare provider when starting ZEPOSIA and when you miss a dose.

Continue reading for additional possible serious side effects of ZEPOSIA.

Before taking ZEPOSIA, tell your healthcare provider about all of your medical conditions, including if you:

  • have a fever or infection, or are unable to fight infections due to a disease, or take or have taken medicines that lower your immune system
  • received a vaccine in the past 30 days or are scheduled to receive a vaccine. ZEPOSIA may cause vaccines to be less effective
  • before you start ZEPOSIA, your healthcare provider may give you a chickenpox (Varicella Zoster Virus) vaccine if you have not had one before
  • have had chickenpox or have received the vaccine for chickenpox. Your healthcare provider may do a blood test for the chickenpox virus. You may need to get the full course of the vaccine and wait 1 month before taking ZEPOSIA
  • have a slow heart rate
  • have an irregular or abnormal heartbeat (arrhythmia)
  • have a history of stroke
  • have or have had heart problems, including a heart attack or chest pain
  • have high blood pressure
  • have liver problems
  • have breathing problems, including during your sleep
  • have eye problems, especially an inflammation of the eye called uveitis
  • have diabetes
  • are or plan to become pregnant or if you become pregnant within 3 months after you stop taking ZEPOSIA. ZEPOSIA may harm your unborn baby. If you are a female who can become pregnant, talk to your healthcare provider about what birth control method is right for you during your treatment with ZEPOSIA and for 3 months after you stop taking ZEPOSIA. If you become pregnant while taking ZEPOSIA for MS, tell your healthcare provider right away and enroll in the ZEPOSIA Pregnancy Registry by calling 1-877-301-9314 or visiting www.zeposiapregnancyregistry.com
  • are breastfeeding or plan to breastfeed. It is not known if ZEPOSIA passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take ZEPOSIA

Tell your healthcare provider about all the medicines you take or have recently taken, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using ZEPOSIA with other medicines can cause serious side effects. Especially tell your healthcare provider if you take or have taken:

  • medicines that affect your immune system, such as alemtuzumab
  • medicines to control your heart rhythm (antiarrhythmics), or heartbeat
  • CYP2C8 inducers such as rifampin
  • CYP2C8 inhibitors such as gemfibrozil (medicine to treat high fat in your blood)
  • opioids (pain medicine), medicines to treat depression, and medicines to treat Parkinson’s disease
  • medicines to control your heart rate and blood pressure (beta blocker medicines and calcium channel blocker medicines)

You should not receive live vaccines during treatment with ZEPOSIA, for at least 1 month before taking ZEPOSIA and for 3 months after you stop taking ZEPOSIA. Vaccines may not work as well when given during treatment with ZEPOSIA.

ZEPOSIA can cause serious side effects, including:

  • liver problems. Your healthcare provider will do blood tests to check your liver before you start taking ZEPOSIA. Call your healthcare provider right away if you have any of the following symptoms:
    • unexplained nausea
    • vomiting
    • stomach area (abdominal) pain
    • tiredness
    • loss of appetite
    • yellowing of the whites of your eyes or skin
    • dark colored urine
  • increased blood pressure. Your healthcare provider should check your blood pressure during treatment with ZEPOSIA. A sudden, severe increase in blood pressure (hypertensive crisis) can happen when you eat certain foods that contain high levels of tyramine.
  • breathing problems. Some people who take ZEPOSIA have shortness of breath. Call your healthcare provider right away if you have new or worsening breathing problems.
  • a problem with your vision called macular edema. Your risk of macular edema is higher if you have diabetes or have had an inflammation of your eye called uveitis. Your healthcare provider should test your vision before you start taking ZEPOSIA if you are at higher risk for macular edema or any time you notice vision changes during treatment with ZEPOSIA. Call your healthcare provider right away if you have any of the following symptoms:
    • blurriness or shadows in the center of your vision
    • sensitivity to light
    • a blind spot in the center of your vision
    • unusually colored vision
  • swelling and narrowing of the blood vessels in your brain. Posterior Reversible Encephalopathy Syndrome (PRES) is a rare condition that has happened with ZEPOSIA and with drugs in the same class. Symptoms of PRES usually get better when you stop taking ZEPOSIA. If left untreated, it may lead to stroke. Your healthcare provider will do a test if you have any symptoms of PRES. Call your healthcare provider right away if you have any of the following symptoms:
    • sudden severe headache
    • sudden confusion
    • sudden loss of vision or other changes in your vision
    • seizure
  • severe worsening of multiple sclerosis (MS) after stopping ZEPOSIA. When ZEPOSIA is stopped, symptoms of MS may return and become worse compared to before or during treatment. Always talk to your healthcare provider before you stop taking ZEPOSIA for any reason. Tell your healthcare provider if you have worsening symptoms of MS after stopping ZEPOSIA.

The most common side effects of ZEPOSIA can include:

  • upper respiratory tract infections
  • elevated liver enzymes
  • low blood pressure when you stand up (orthostatic hypotension)
  • painful and frequent urination (signs of urinary tract infection)
  • back pain
  • high blood pressure
  • headache

These are not all of the possible side effects of ZEPOSIA. For more information, ask your healthcare provider or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

INDICATIONS

Multiple Sclerosis (MS): ZEPOSIA® (ozanimod) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Ulcerative Colitis (UC): ZEPOSIA is a prescription medicine used to treat moderately to severely active ulcerative colitis (UC) in adults.

It is not known if ZEPOSIA is safe and effective in children.

Please see full Prescribing Information, including Medication Guide.

Back to Top